According to a study conducted in the US, the prevalence of cerebral palsy is found in 0.2% of drooling patents aged between three and 17 years.
-
Cuvposa was developed by Sciele Pharma. -
Drooling is found to affect about 10 to 30% of paediatric patients suffering... -
According to a study conducted in the US, the prevalence of cerebral palsy is...